Cookies help us deliver our services. By using our services, you agree to our use of cookies.
Learn more
OK
Skip to main content (Press Enter).
Sign In
Skip auxiliary navigation (Press Enter).
Contact Us
Skip main navigation (Press Enter).
Toggle navigation
Search Options
About
What is the AMS
AMS International Scientific Committee
AMS Educational Executive Committee
AMS Ambassadors
Upcoming Events
Videos & Webinars
International Events
Become a Speaker
Videos On Demand
Education 365
Features
AMS Features
Blogs
Industry
Industry Partners
Become a Sponsor
Features
Blogs
Blog Viewer
Blogs
On which evidence can we rely when prescribing off-label methotrexate in dermatological practice? – a systematic review with GRADE approach
By
Aesthetic Multispecialty Society
posted
Aug 24, 2021 08:41 AM
0
Recommend
.
0 comments
0 views
Related Content
Off-label studies on ruxolitinib in dermatology: a review
Aesthetic Multispecialty Society
Added Jun 09, 2020
Blog Entry
Off-Label studies on anakinra in dermatology: a review
Aesthetic Multispecialty Society
Added Apr 22, 2020
Blog Entry
Off-label dermatologic uses of IL-17 inhibitors
Aesthetic Multispecialty Society
Added Mar 09, 2020
Blog Entry
Topical methotrexate in dermatology: a review of the literature
Aesthetic Multispecialty Society
Added May 25, 2020
Blog Entry
New evidence-based resources to guide treatment of plaque psoriasis
Aesthetic Multispecialty Society
Added Sep 08, 2021
Blog Entry
Permalink
© 2022 AMS, Aesthetic Multispecialty Society. All Rights Reserved.
Powered by Higher Logic